Targeted metabolomic analysis reveals the association between the postprandial change in palmitic acid, branched-chain amino acids and insulin resistance in young obese subjects

Diabetes Research and Clinical Practice

Volumn 108, Issue 1, 2015, Pages 84-93

  Liu, Liyan ^a   Feng, Rennan ^a   Guo, Fuchuan ^a   Li, Ying ^a   Jiao, Jundong ^a   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Amino acids; Fatty acids; Insulin resistance; Obesity; Oral glucose tolerance test

Indexed keywords

4 AMINOBUTYRIC ACID; ARGININE; ASPARAGINE; BIOGENIC AMINE; BRANCHED CHAIN AMINO ACID; CHOLESTEROL; CREATINE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; HISTIDINE; INSULIN; ISOLEUCINE; LEUCINE; LYSINE; PALMITIC ACID; PHENYLALANINE; PROLINE; TAURINE; TRIACYLGLYCEROL; TRYPTOPHAN; VALINE;

ADULT; AMINO ACID BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; BODY FAT; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FAT MASS; FATTY ACID BLOOD LEVEL; HIP CIRCUMFERENCE; HOMEOSTATIC MODEL OF ASSESSMENT INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; SYSTOLIC BLOOD PRESSURE; TARGETED METABOLOMICS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY TRIPLE QUADRUPOLE MASS SPECTROMETRY; VALIDATION PROCESS; WAIST CIRCUMFERENCE; YOUNG ADULT; ADOLESCENT; BLOOD; COMPLICATION; DIET RESTRICTION; ENERGY METABOLISM; FEMALE; GLUCOSE TOLERANCE TEST; MALE; PHYSIOLOGY;

ADOLESCENT; ADULT; AMINO ACIDS, BRANCHED-CHAIN; ENERGY METABOLISM; FASTING; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PALMITIC ACID; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 84926139524     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.01.014     Document Type: Article

References (35)

1. Choi J.H., Banks A.S., Estall J.L., Kajimura S., Boström P., Laznik D., et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 2010, 466:451-456.
2. World Health Organization (WHO) Global strategy on diet, physical activity and health 2011, WHO, 〈http://www.who.int/dietphysicalactivity/childhood/en/〉 (accessed 18 December 2012) [WWW document].
3. Kissebah A.H., Vydelingum N., Murray R., Evans D.J., Hartz A.J., Kalkhoff R.K., et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982, 54(2):254-260.
4. Wang X., Zhang A., Han Y., Wang P., Sun H., Song G., et al. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012, 11:370-380.
5. Morris C., O'Grada C., Ryan M., Roche H.M., Gibney M.J., Gibney E.R., et al. The relationship between BMI and metabolomic profiles: a focus on amino acids. Proc Nutr Soc 2012, 71:634-638.
6. Oberbach A., Blüher M., Wirth H., Till H., Kovacs P., Kullnick Y., et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 2011, 10:4769-4788.
7. Huffman K.M., Shah S.H., Stevens R.D., Bain J.R., Muehlbauer M., Slentz C.A., et al. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 2009, 32:1678-1683.
8. Pietiläinen K.H., Sysi-Aho M., Rissanen A., Seppänen-Laakso T., Yki-Järvinen H., Kaprio J., et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. PLoS ONE 2007, 2:E768-E774.
9. Kochhar S., Jacobs D.M., Ramadan Z., Berruex F., Fuerholz A., Fay L.B. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal Biochem 2006, 352:274-281.
10. Shaham O., Wei R., Wang T.J., Ricciardi C., Lewis1 G.D., Vasan R.S., et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008, 4:1-9.
11. Bentley-Lewis R., Xiong G., Lee H., Yang A., Huynh J., Kim C. Metabolomic analysis reveals amino-acid responses to an oral glucose tolerance test in women with prior history of gestational diabetes mellitus. J Clin Transl Endocrinol 2014, 1:38-43.
12. World Health Organization The Asia-Pacific perspective: redefining obesity and its treatment 2000, Health Communications Australia Pty Limited, New South Wales.
13. Liu L.Y., Li Y., Guan C.M., Li K., Wang C., Sun C.H. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B: Anal Technol Biomed Life Sci 2010, 878:2817-2825.
14. Leung N., Sakaue T., Carpentier A., Uffelman K., Giacca A., Lewis G.F. Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24h of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia 2004, 47:204-213.
15. Nakatsuji H., Kishida K., Kitamura T., Nakajima C., Funahashi T., Shimomura I. Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity. Metab Clin Exp 2010, 59(4):520-526.
16. Chu X., Liu L.Y., Na L.X., Lu H., Li S., Li Y., et al. Sterol regulatory element-binding protein-1c mediates increase of postprandial stearic acid, potential target for improving insulin resistance, in hyperlipidemia. Diabetes 2013, 62:561-571.
17. Spegel P., Danielsson A.H., Bacos K., Nagorny C.F., Moritz T., Mulder H., et al. Metabolomic analysis of a human oral glucose tolerance test reveals fatty acids as reliable indicators of regulated metabolism. Metabolomics 2010, 6:56-66.
18. Rockett B.D., Salameh M., Carraway K., Morrison K., Shaikh S.R. n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cytokine secretion in vitro and ex vivo. J Lipid Res 2010, 51:1284-1297.
19. Hunnicutt J.W., Hardy R.W., Williford J., McDonald J.M. Saturated fatty acid induced insulin resistance in rat adipocytes. Diabetes 1994, 43:540-545.
20. Staiger H., Staiger K., Stefan N., Wahl H.G., Machicao F., Kellerer M., et al. Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 2004, 53:3209-3216.
21. Weigert C., Brodbeck K., Staiger H., Kausch C., Machicao F., Haring H.U., et al. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasomedependent activation of nuclear factor-kappaB. J Biol Chem 2004, 279:23942-23952.
22. Felig P., Marliss E., Cahill G.F. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969, 281:811-816.
23. Felig P., Wahren J., Hendler R., Brundin T. Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest 1974, 53:582-590.
24. Holěcek M. The BCAA-BCKA cycle: its relation to alanine and glutamine synthesis and protein balance. Nutrition 2001, 17:70.
25. Doi M., Yamaoka I., Nakayama M., Sugahara K., Yoshizawa F. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am J Physiol 2007, 292:E1683-E1693.
26. Lynch C.J., Gern B., Lloyd C., Hutson S.M., Eicher R., Vary T.C. Leucine in food mediates some of the postprandial rise in plasma leptin concentrations. Am J Physiol 2006, 291:E621-E630.
27. Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009, 9:311-326.
28. Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011, 17:448-453.
29. Shaham O., Wei R., Wang T.J., Ricciardi C., Lewis G.D., Vasan R.S., et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008, 4:214.
30. Geidenstam N., Spégel P., Mulder H., Filipsson K., Ridderstråle M., Anders P.H., et al. Danielsson metabolite profile deviations in an oral glucose tolerance test-a comparison between lean and obese individuals. Obesity 2014, 22(11):2388-2395.
31. Zhou Y., Qiu L., Xiao Q., Wang Y., Meng X., Xu R., et al. Obesity and diabetes related plasma amino acid alterations. Clin Biochem 2013, 46:1447-1452.
32. Tai E.S., Tan M.L., Stevens R.D., Low Y.L., Muehlbauer M.J., Goh D.L., et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 2010, 53:757-767.
33. Niu Y.C., Feng R.N., Hou Y., Li K., Kang Z., Wang J., et al. Histidine and arginine are associated with inflammation and oxidative stress in obese women. Br J Nutr 2012, 108(1):57-61.
34. Yoshimatsu H., Chiba S., Tajima D., Akehi Y., Sakata T. Histidine suppresses food intake through its conversion into neuronal histamine. Exp Biol Med (Maywood) 2002, 227:63-68.
35. Lucotti P., Setola E., Monti L.D., Galluccio E., Costa S., Sandoli E.P., et al. Beneficial effects of a long-term oral l-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulinresistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006, 291:E906-E912.